Concord Biotech Ltd

  • BSE Code : 543960
  • NSE Symbol : CONCORDBIO
  • ISIN : INE338H01029
  • Industry :PHARMACEUTICALS - INDIAN - BULK DRUGS & FORMLN

up-arrow 1,025.10 5.10(0.50%)

Open Price ()

1,016.00

Prev. Close ()

1,020.00

Volume (No’s)

202,540

Market Cap ()

10,724.21

Low Price ()

987.00

High Price ()

1,030.00

 

Book Closure

From Date To Date Announcement
11-Feb-2026 NA Concord Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/02/2026 inter alia to consider and approve the unaudited standalone and consolidated financial results of the Company for the quarter and nine months period ended 31 December 2025. On recommendation of the Nomination and Remuneration Committee, the Board of Directors of the Company, appointed Mr. Paritosh Trivedi (A63623) as Company Secretary, Compliance Officer and Nodal Officer of the Company with effect from February 11, 2026. The Board of Directors of the Company, at its meeting held today i.e. Wednesday, February 11, 2026, has inter-alia; 1. UNAUDITED FINANCIAL RESULTS : On review and recommendation of Audit Committee of the Company the Board approved Unaudited Standalone and Consolidated Financial Results for the Third quarter and Nine months ended on December on 31, 2025. 2. APPOINTMENT OF KEY MANAGERIAL PERSONNEL On the recommendation of the Nomination and Remuneration Committee, the Board of Directors of the Company, appointed Mr. Paritosh Trivedi (A63623) as Company Secretary, Compliance Officer and Nodal Officer of the Company with effect from February 11, 2026. (As per BSE announcement dated on : 11.02.2026)
11-Feb-2026 NA On recommendation of the Nomination and Remuneration Committee, the Board of Directors of the Company, appointed Mr. Paritosh Trivedi (A63623) as Company Secretary, Compliance Officer and Nodal Officer of the Company with effect from February 11, 2026
21-Jan-2026 NA Ms. Hina Patel, has tendered her resignation from the post of Company Secretary and Compliance Officer w.e.f 21/01/2026 after close of working hours.
05-Jan-2026 NA Early retirement of Chief Financial Officer
18-Dec-2025 NA Appointment of Mr. Raviraj Karia as Chief Financial Officer and KMP

Copyright © 2026 Arihant Capital Markets Ltd. All rights Reserved.

Designed, Developed and Content powered by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)

x
  • QR-CodeNew